EPO Patents = 2

Trademarks = 1

Forward Citations = 22

Loading Chart...

5 inventors (with patents filed for the assignee):

Aladar A Szalay (5 out of 44 patents)

Boris Minev (4 out of 10 patents)

Dobrin Draganov (2 out of 2 patents)

4. Duong Hoang Nguyen (1 out of 1 patent)

5. Antonio Fernandez Santidrian (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 11655455 - Enhanced systems for cell-mediated oncolytic viral therapy (2023-05-23),

2. 11607450 - Smallpox vaccine for cancer treatment (2023-03-21),

3. 11505782 - Cell-based vehicles for potentiation of viral therapy (2022-11-22),

4. 11285194 - Combination immunotherapy approach for treatment of cancer (2022-03-29),

5. 10857225 - Smallpox vaccine for cancer treatment (2020-12-08),

6. 10105436 - Smallpox vaccine for cancer treatment (2018-10-23),

Company Overview

Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company focused on the development of novel oncolytic virus-based therapeutics for the treatment of cancer. Our proprietary technology platform enables the targeted delivery of therapeutic payloads to cancer cells, while sparing normal cells. Through our innovative approach, we aim to revolutionize cancer treatment and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#56 in La Jolla, CA

#10,570 in California

#44,897 in US

La Jolla, CA, United States of America

Calidi Biotherapeutics, Inc.

Forward Citations = 22

5 inventors:

Aladar A Szalay (5 out of 44 patents)

Boris Minev (4 out of 10 patents)

Dobrin Draganov (2 out of 2 patents)

4. Duong Hoang Nguyen (1 out of 1 patent)

5. Antonio Fernandez Santidrian (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Calidi Biotherapeutics, Inc.. Retrieved from https://idiyas.com/company/calidi-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]